Company Overview of ImQuest Pharmaceuticals, Inc
ImQuest Pharmaceuticals, Inc. develops drugs for the treatment of infectious diseases, cancer, and inflammation. The company focuses on various drug development programs, such as therapies for the treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and cancer, as well as on topical microbicides for the prevention of transmission of HIV and other sexually transmitted infections. It develops a vaginal gel for the prevention of HIV transmission to women. The company was founded in 2005 and is based in Frederick, Maryland.
7340 Executive Way
Frederick, MD 21704
Founded in 2005
Key Executives for ImQuest Pharmaceuticals, Inc
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ImQuest Pharmaceuticals, Inc, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.